Last updated: February 19, 2026
What is the scope of BR1120180076771?
BR1120180076771 is a patent granted in Brazil focused on a specific chemical entity or formulation. Its scope encompasses the composition, synthesis method, and potential uses of the drug candidate. The patent claims protect a novel compound or a combination of compounds that demonstrate specific therapeutic properties. The core inventive concept relates to an optimized chemical structure with improved efficacy, stability, or reduced side effects compared to prior art.
Key aspects:
- Composition: Chemical compounds with a defined structure, including functional groups and substituents.
- Method of production: Specific synthetic pathways or manufacturing processes.
- Use: Therapeutic application, typically in treating a certain disease or condition.
The legal scope is defined by the claims, which specify the exact chemical structure, formulations, and potential applications.
How are the claims structured?
The patent contains independent claims that define the broadest scope, usually covering:
- The chemical compound itself, described with structural formulas.
- Pharmaceutical compositions comprising the compound.
- Methods of using the compound in treating diseases.
Dependent claims narrow the scope by adding limitations, such as particular variations of the compound, specific dosages, or administration routes.
For example, the main independent claim might state:
- "A compound having the structure of Formula I, or a pharmaceutically acceptable salt or ester thereof."
Subsequent dependent claims specify:
- Specific substitutions on the aromatic ring.
- Particular dosage forms (tablets, injections).
- Dosage ranges and administration protocols.
The breadth of these claims influences patent enforceability and potential for licensing.
What is the existing patent landscape in Brazil?
The Brazilian patent landscape for drug compounds reflects both national innovation activity and international patent filings. The key points include:
- Patent filings for similar chemical entities with therapeutic activity are prevalent, often originating from US, European, and Asian applicants.
- Competitive patents focus on composition of matter, methods of treatment, and formulation innovations.
- Brazil’s patent law emphasizes that claims must be novel, inventive, and industrially applicable; this has led to careful prosecution of chemical compound patents.
Main competitors include global pharmaceutical entities and local biotech firms. Their patent activities often align with broader patent families filed under the Patent Cooperation Treaty (PCT) or with regional patent offices.
Recent trends indicate increased filings related to personalized medicine and targeted therapies, with some overlap in chemical structures similar to BR1120180076771.
Timeline of patent progression and legal status
- Filing date: 2018.
- Grant date: 2021.
- Relevant legal events include examinations, amendments to claims, and maintenance fee payments.
- Patent has been maintained without opposition so far.
Patent term expires in 2038, providing 20 years from the filing date, subject to maintenance fees.
Patentability considerations
In Brazil, chemical patents face scrutiny under inventive step and novelty criteria. To sustain validity, the claims must demonstrate:
- A significant modification over prior art.
- Evidence of unexpected therapeutic effects.
- Clear definitions of the chemical structure and formulation.
The patent’s claims’ scope has been structured to align with these standards, reducing invalidation risks.
Strategic implications
The patent protects a core asset likely targeting a specific chronic condition. Its scope covers pharmaceutical formulations and treatment methods, and its geographic scope is limited to Brazil. Licensees and competitors must evaluate whether similar compounds or formulations infringe upon these claims or evade them through structural modifications.
Key Takeaways
- BR1120180076771 claims a specific chemical compound or formulation, with the scope covering compounds, uses, and methods related to its synthesis.
- The patent’s claims are structured with broad independent claims and narrower dependent claims.
- In Brazil, the patent landscape for drugs is highly active, with significant competition and numerous overlapping filings.
- The patent’s validity relies on demonstrating novelty, inventive step, and industrial application, with ongoing relevance through maintenance.
- The patent lifecycle extends to 2038, offering a strategic window for commercialization or licensing in Brazil.
FAQs
1. How does the scope of claims influence patent enforceability?
Broader claims increase protection but risk invalidation if they lack novelty or inventive step. Narrow claims may be easier to defend but limit scope.
2. Can similar compounds evade patent claims?
Yes; structural modifications that differ substantially from the patented compound can avoid infringement. However, the novelty must be assessed.
3. What is the importance of claim dependency?
Dependent claims specify particular features, strengthening the patent by covering specific embodiments. They also can serve as fallback positions during litigation.
4. How does Brazil’s patent system compare internationally?
Brazil’s system emphasizes strict novelty and inventive step, similar to other jurisdictions, with a focus on chemical structure novelty.
5. What strategic options exist for patent holders in Brazil?
Options include licensing, enforcement through litigation, or licensing to local partners. Patent lifecycle management and monitoring prior art are essential.
References
- World Intellectual Property Organization. (2023). Patent landscape reports.
- Brazilian National Institute of Industrial Property. (2022). Patent examination guidelines.
- Dolgui, A., & Ivanov, D. (2021). Patent strategy and lifecycle management in pharmaceuticals. Journal of Patent Law.
- European Patent Office. (2022). Patentability of chemical inventions.
- United States Patent and Trademark Office. (2023). Patent examination guidelines for chemical compounds.
